New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
+4.89%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$76.2B
AUM Growth
+$462M
(+0.61%)
Cap. Flow
-$1.66B
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
30.9%
Holding
3,465
New
232
Increased
1,719
Reduced
1,283
Closed
68
Top Buys
| 1 |
CRH
CRH
|
+$72.2M |
| 2 |
Exxon Mobil
XOM
|
+$71.1M |
| 3 |
GE Vernova
GEV
|
+$69.6M |
| 4 |
CrowdStrike
CRWD
|
+$50.7M |
| 5 |
Amphenol
APH
|
+$47M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
Amazon
AMZN
|
+$157M |
| 3 |
TSMC
TSM
|
+$136M |
| 4 |
NVIDIA
NVDA
|
+$98.4M |
| 5 |
Applied Materials
AMAT
|
+$88M |
Sector Composition
| 1 | Technology | 32.51% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
2601
DELISTED
NEVRO CORP.
NVRO
| $122K | ﹤0.01% |
14,503
+115
| +0.8% | +$967 |
|
2602
Takeda Pharmaceutical
TAK
$48.5B
| $121K | ﹤0.01% |
9,368
| – | – |
|
|
TBI
2603
Trueblue
TBI
$176M
| $121K | ﹤0.01% |
11,756
-602
| -5% | -$6.2K |
|
2604
Kearny Financial
KRNY
$420M
| $120K | ﹤0.01% |
19,585
+320
| +2% | +$1.96K |
|
2605
Terns Pharmaceuticals
TERN
$653M
| $120K | ﹤0.01% |
17,571
| – | – |
|
2606
Tourmaline Bio
TRML
$1.22B
| $120K | ﹤0.01% |
+9,300
| New | +$120K |
|
2607
ACNB Corp
ACNB
$476M
| $119K | ﹤0.01% |
3,271
| – | – |
|
2608
Bit Digital
BTBT
$948M
| $119K | ﹤0.01% |
37,416
-189
| -0.5% | -$601 |
|
2609
Pacific Biosciences
PACB
$378M
| $119K | ﹤0.01% |
86,625
+2,125
| +3% | +$2.92K |
|
2610
Tyra Biosciences
TYRA
$665M
| $119K | ﹤0.01% |
7,423
-24,726
| -77% | -$396K |
|
2611
Funko
FNKO
$186M
| $118K | ﹤0.01% |
12,112
+37
| +0.3% | +$360 |
|
2612
Graham Corp
GHM
$543M
| $118K | ﹤0.01% |
+4,200
| New | +$118K |
|
2613
Anywhere Real Estate
HOUS
$764M
| $118K | ﹤0.01% |
35,610
+730
| +2% | +$2.42K |
|
2614
Orion Group Holdings
ORN
$306M
| $118K | ﹤0.01% |
+12,400
| New | +$118K |
|
2615
South Plains Financial
SPFI
$651M
| $118K | ﹤0.01% |
4,375
-1
| -0% | -$27 |
|
2616
TScan Therapeutics
TCRX
$104M
| $118K | ﹤0.01% |
+20,093
| New | +$118K |
|
2617
Q32 Bio
QTTB
$23.8M
| $118K | ﹤0.01% |
+6,600
| New | +$118K |
|
2618
Aehr Test Systems
AEHR
$795M
| $117K | ﹤0.01% |
10,433
+5
| +0% | +$56 |
|
2619
Alector
ALEC
$289M
| $117K | ﹤0.01% |
25,810
+372
| +1% | +$1.69K |
|
2620
Princeton Bancorp
BPRN
$217M
| $117K | ﹤0.01% |
3,543
| – | – |
|
2621
First Bank
FRBA
$420M
| $117K | ﹤0.01% |
9,152
+1
| +0% | +$13 |
|
2622
J. Jill
JILL
$279M
| $117K | ﹤0.01% |
3,338
-1
| -0% | -$35 |
|
2623
Phibro Animal Health
PAHC
$1.67B
| $117K | ﹤0.01% |
6,972
-33,767
| -83% | -$567K |
|
2624
Lunai Bioworks Inc. Common Stock
RENB
$46.6M
| $117K | ﹤0.01% |
+66,700
| New | +$117K |
|
2625
Xperi
XPER
$280M
| $117K | ﹤0.01% |
14,300
+32
| +0.2% | +$262 |
|